Amundi Asset Management US’s United Therapeutics UTHR Stock Holding History

Amundi Asset Management US’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$503K	Buy	+3,008	New	+$502K	﹤0.01%	1324
2020 Q2	–	Sell	-5,026	Closed	-$477K	–	1685
2020 Q1	$477K	Sell	5,026 -10,726	-68%	-$1.02M	﹤0.01%	1208
2019 Q4	$1.39M	Sell	15,752 -9,272	-37%	-$816K	﹤0.01%	1190
2019 Q3	$2M	Sell	25,024 -20,233	-45%	-$1.63M	﹤0.01%	1108
2019 Q2	$3.53M	Sell	45,257 -30,964	-41%	-$2.9M	﹤0.01%	1035
2019 Q1	$8.95M	Buy	76,221 +12,087	+19%	+$1.41M	0.01%	737
2018 Q4	$6.98M	Buy	64,134 +37,086	+137%	+$4.3M	0.01%	754
2018 Q3	$3.46M	Buy	27,048 +2,306	+9%	+$285K	﹤0.01%	1006
2018 Q2	$2.8M	Buy	24,742 +9,688	+64%	+$1.06M	﹤0.01%	1052
2018 Q1	$1.69M	Sell	15,054 -12	-0.1%	-$1.52K	﹤0.01%	1094
2017 Q4	$2.23M	Buy	+15,066	New	+$1.92M	﹤0.01%	1056

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Amundi Asset Management US's UTHR Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in United Therapeutics (UTHR) in Q1 2021: 3,008 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #1324 among its holdings. This is a return to the name: Amundi Asset Management US previously reported a position in UTHR as recently as Q1 2020.

Amundi Asset Management US first reported a position in UTHR in Q4 2017 and has held it in 11 quarters since. The position peaked at $8.95M in Q1 2019. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

Amundi Asset Management US held 3,008 shares of United Therapeutics worth $503K as of Q1 2021.
United Therapeutics was a new Amundi Asset Management US position in Q1 2021.
United Therapeutics made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1324 holding.
Amundi Asset Management US first reported a position in United Therapeutics in Q4 2017 and has held it in 11 quarters since.
Amundi Asset Management US's United Therapeutics position peaked at $8.95M in Q1 2019.
391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.